Jun
25
2019
On demand

NextGen now - Delivering tomorrow’s facilities today

Modeling multiple variations of a typical gene-modified cell therapy facility enables both a thorough examination of company and industry-wide challenges, and exploration of alternative/future models for the cell & gene therapy manufacturing sector. This presentation educates attendees on the different technologies, layouts and delivery options available.

Watch this On Demand webinar with Marc Pelletier, PhD, Director, Strategic Consulting, CRB and Ryan McDonough, Senior Associate, Biotechnology Core Team Leader, CRB, as they discuss how to:

  • Discover how logistics optimization and enabling technologies can create a facility design that reduces overhead costs, allows pipeline expandability and production of a higher quality therapeutic.
  • Gain a step-by-step understanding of the best way to build your facility.
  • Compare costs and schedules for various facility construction models.

Marc Pelletier
Director at CRB
Ryan McDonough
Senior Associate, Biotechnology Core Team Leader at CRB

SPEAKERS

Marc Pelletier
Director at CRB
Ryan McDonough
Senior Associate, Biotechnology Core Team Leader at CRB

You might also like

Thinking translational: Things to consider in CAR T cell research workflows

S Rösch, PhD
Saskia Rösch, PhD
Saskia Rösch, PhD
Global Product Manager at Miltenyi Biotec
22 Jun 2022
35
Days
0
Hrs
39
Min
Register

Optimizing mRNA purification conditions by using a Design of Experiments...

J England
Jenny England
Jenny England
Application Scientist and Innovation Leader at Thermo Fisher Scientific
14 Jun 2022
27
Days
0
Hrs
39
Min
Register

Monitoring of circulating CAR T cells

A Graband,
D Hünecke,
D Bremm
Annika Graband
Annika Graband
Product Manager, Cell Analysis Reagents at Miltenyi Biotec
Dr. Sabine Hünecke
Dr. Sabine Hünecke
Head of Laboratory, Stem Cell Transplantation and Immunotherapy at University Hospital Frankfurt
Dr. Melanie Bremm
Dr. Melanie Bremm
Deputy Head of Laboratory, Stem Cell Transplantation and Immunotherapy at University Hospital Frankfurt
31 May 2022
13
Days
0
Hrs
39
Min
Register

Improving T cell therapy manufacturing processes with automation and...

E Zynda, PhD
Evan Zynda, PhD
Evan Zynda, PhD
Staff Scientist, Cell Biology at Thermo Fisher Scientific
26 May 2022
8
Days
0
Hrs
39
Min
Register

Streamlined workflow solutions for cell and gene therapy analytics

A Graband
Annika Graband
Annika Graband
Product Manager, Cell Analysis Reagents at Miltenyi Biotec
24 May 2022
6
Days
0
Hrs
39
Min
Register